Abstract:The gingival epithelium is a physical and immunological barrier to the microbiota of the oral cavity, which interact through soluble mediators with the immune cells that patrol the tissue at the gingival epithelium. We sought to develop a three-dimensional gingivae-biofilm interface model using a commercially available gingival epithelium to study the tissue inflammatory response to oral biofilms associated with “health”, “gingivitis” and “periodontitis”. These biofilms were developed by sequential addition of… Show more
“…To assess the effect of IONPs-CS-MCZ on pathogenic biofilms, three different in vitro multi-species biofilm models were tested, representative of caries, denture and gingivitis developed as previously described [4,27,28]. For all biofilm models, the bacterial and fungal cells were adjusted to 1 × 10 7 cells/mL in Todd Hewitt Broth (THB) medium supplemented with 0.01 mg/mL hemin and 2 µg/mL menadione [29].…”
Section: Multi-species Biofilm Models and Treatmentmentioning
confidence: 99%
“…Biofilm development for all models used followed similar protocols as described previously [4,27,28,30]. Briefly, biofilm formation consisted of inoculating Streptococcus species and C. albicans(500 µL) on the first day to promote primary colonization, followed by the addition of the remaining species on the second day.…”
Section: Multi-species Biofilm Models and Treatmentmentioning
confidence: 99%
“…For qPCR,1 µL of sample DNA was added to a mastermix solution containing 10 µL of SYBR GreenER TM (Thermo-Fisher, UK), 7 µL of UV-treated RNase-free water and 1 µL of 10 µM forward/reverse primers for each microbial genus or species. Table 1 displays the primers used in the study [4,27,28]. A total volume of 20 μl was added to MicroAmp fast-optical 96-well 0.1 ml reaction plates (Applied Biosystems, USA) and loaded into the StepOnePlus™ real time system (Applied Biosystems, USA).…”
Background: Novel and new therapeutic strategies capable of enhancing the efficacy of existing antimicrobials is an attractive proposition to meet the needs of society. Objective: This study aimed to evaluate the potentiating effect of a miconazole (MCZ) nanocarrier system, incorporated with iron oxide nanoparticles (IONPs) and chitosan (CS) (IONPs-CS-MCZ). This was tested on three representative complex interkingdom oral biofilm models (caries, denture and gingivitis). Materials and methods: The planktonic and sessile minimum inhibitory concentrations (MICs) of IONPs-CS-MCZ against different Candida albicans strains were determined, as well as against all represented bacterial species that formed within the three biofilm models. Biofilms were treated for 24 hours with the IONPs-CS nanocarrier system containing MCZ at 64 mg/L, and characterized using a range of bioassays for quantitative and qualitative assessment. Results: MIC results generally showed that IONPs-CS-MCZ was more effective than MCZ alone. IONPs-CS-MCZ also promoted reductions in the number of CFUs, biomass and metabolic activity of the representative biofilms, as well as altering biofilm ultrastructure when compared to untreated biofilms. IONPs-CS-MCZ affected the composition and reduced the CFEs for most of the microorganisms present in the three evaluated biofilms. In particular, the proportion of streptococci in the biofilm composition were reduced in all three models, whilst Fusobacterium spp. percentage reduced in the gingivitis and caries models, respectively. Conclusion: In conclusion, the IONPs-CS-MCZ nanocarrier was efficient against three in vitro models of pathogenic oral biofilms, showing potential to possibly interfere in the synergistic interactions among fungal and bacterial cells within polymicrobial consortia.
“…To assess the effect of IONPs-CS-MCZ on pathogenic biofilms, three different in vitro multi-species biofilm models were tested, representative of caries, denture and gingivitis developed as previously described [4,27,28]. For all biofilm models, the bacterial and fungal cells were adjusted to 1 × 10 7 cells/mL in Todd Hewitt Broth (THB) medium supplemented with 0.01 mg/mL hemin and 2 µg/mL menadione [29].…”
Section: Multi-species Biofilm Models and Treatmentmentioning
confidence: 99%
“…Biofilm development for all models used followed similar protocols as described previously [4,27,28,30]. Briefly, biofilm formation consisted of inoculating Streptococcus species and C. albicans(500 µL) on the first day to promote primary colonization, followed by the addition of the remaining species on the second day.…”
Section: Multi-species Biofilm Models and Treatmentmentioning
confidence: 99%
“…For qPCR,1 µL of sample DNA was added to a mastermix solution containing 10 µL of SYBR GreenER TM (Thermo-Fisher, UK), 7 µL of UV-treated RNase-free water and 1 µL of 10 µM forward/reverse primers for each microbial genus or species. Table 1 displays the primers used in the study [4,27,28]. A total volume of 20 μl was added to MicroAmp fast-optical 96-well 0.1 ml reaction plates (Applied Biosystems, USA) and loaded into the StepOnePlus™ real time system (Applied Biosystems, USA).…”
Background: Novel and new therapeutic strategies capable of enhancing the efficacy of existing antimicrobials is an attractive proposition to meet the needs of society. Objective: This study aimed to evaluate the potentiating effect of a miconazole (MCZ) nanocarrier system, incorporated with iron oxide nanoparticles (IONPs) and chitosan (CS) (IONPs-CS-MCZ). This was tested on three representative complex interkingdom oral biofilm models (caries, denture and gingivitis). Materials and methods: The planktonic and sessile minimum inhibitory concentrations (MICs) of IONPs-CS-MCZ against different Candida albicans strains were determined, as well as against all represented bacterial species that formed within the three biofilm models. Biofilms were treated for 24 hours with the IONPs-CS nanocarrier system containing MCZ at 64 mg/L, and characterized using a range of bioassays for quantitative and qualitative assessment. Results: MIC results generally showed that IONPs-CS-MCZ was more effective than MCZ alone. IONPs-CS-MCZ also promoted reductions in the number of CFUs, biomass and metabolic activity of the representative biofilms, as well as altering biofilm ultrastructure when compared to untreated biofilms. IONPs-CS-MCZ affected the composition and reduced the CFEs for most of the microorganisms present in the three evaluated biofilms. In particular, the proportion of streptococci in the biofilm composition were reduced in all three models, whilst Fusobacterium spp. percentage reduced in the gingivitis and caries models, respectively. Conclusion: In conclusion, the IONPs-CS-MCZ nanocarrier was efficient against three in vitro models of pathogenic oral biofilms, showing potential to possibly interfere in the synergistic interactions among fungal and bacterial cells within polymicrobial consortia.
“…Following co-culture with C. auris , epithelial tissue was carefully cut from the 0.5 cm 2 insert using a 19-gauge needle and washed three times in sterile PBS to remove non-adherent cells in a similar manner as previously described [25], as summarized in the schematic in Figure 1. Tissue was then fixed in 10% neutral-buffered formalin prior to embedding in paraffin.…”
1Candida auris is an enigmatic yeast that provides substantial global risk in 2 healthcare facilities and intensive care units. A unique phenotype exhibited by 3 certain isolates of C. auris is their ability to form small clusters of cells known as 4 aggregates, which have been to a limited extent described in the context of 5 pathogenic traits. In this study, we screened several non-aggregative and 6 aggregative C. auris isolates for biofilm formation, where we observed a level of 7 heterogeneity amongst the different phenotypes. Next, we utilised an RNA-8 sequencing approach to investigate the transcriptional responses during biofilm 9 formation of a non-aggregative and aggregative isolate of the initial pool. 10 Observations from these analyses indicate unique transcriptional profiles in the two 11 isolates, with several genes identified relating to proteins involved in adhesion and 12 invasion of the host in other fungal species. From these findings we investigated for 13 the first time the fungal recognition and inflammatory responses of a three-14 dimensional skin epithelial model to these isolates. In these models, a wound was 15 induced to mimic a portal of entry for C. auris. We show both phenotypes elicited 16 minimal response in the model minus induction of the wound, yet in the wounded 17 tissue both phenotypes induced a greater response, with the aggregative isolate 18 more pro-inflammatory. This capacity of aggregative C. auris biofilms to generate 19 such responses in the wounded skin highlights how this opportunistic yeast is a high 20 risk within the intensive care environment where susceptible patients have multiple 21 indwelling lines.22 23
“…Пцр-диагностика позволяет в более короткие сроки, с меньшими трудозатратами и с большей точностью выявлять наличие генетического матери-original research Stomatology Оригинальные исследОвания Стоматология С воеобразие пародонтита как сосудисто-нервной дистрофии тканей пародонта состоит в том, что на начальных стадиях патологический процесс в тканях пародонта протекает в форме классического острого экссудативного воспаления с сочетанием явлений альтерации, экссудации и пролиферации, но при этом не происходит репарации поврежденных тканей и восстановления гомеостаза, так как процесс приобретает признаки хронического воспаления [1,2]. Среди прочего это обусловлено длительной и постоянной персистенцией пародонтопатогенной микрофлоры и развитием в последующем необратимой деструкции периодонта и альвеолярной кости, а также системными нарушениями иммунной системы с соответствующими морфологическими изменениями тканей, с изменениями когнитивной функции ЦНС [3][4][5]. Видовой состав микрофлоры варьирует в зависимости от тяжести течения процесса и от индивидуальных особенностей микробиоценоза полости рта [6,7].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.